FDA approves treatment for Clostridium difficile infection

Posted by Food and Drug Administration--Press Releases on Friday May 27, 2011 Under News

The U.S. Food and Drug Administration today approved Dificid (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD).

Be Sociable, Share!

Comments are closed.